Table 1.
Past and current substance use in adults with Attention-Deficit/Hyperactivity Disorder (A-ADHD) with Substance Use Disorders (SUDs).
| Substance | Substance Use | Factor Analysis * | ||||
|---|---|---|---|---|---|---|
| Never n (%) |
Past n (%) |
Current n (%) |
Past/Current n (%) |
S-CNS Alcohol |
THC BDZ |
|
| THC | 9 (12.5) | 14 (19.4) | 5 (6.9) | 44 (61.1) | 0.08 | −0.82 |
| Cocaine | 29 (40.3) | 12 (16.7) | 2 (2.8) | 29 (40.3) | 0.58 | 0.07 |
| MDMA | 54 (75.0) | 12 (16.7) | 2 (2.8) | 29 (40.3) | 0.89 | −0.12 |
| Amphetamines | 58 (80.6) | 11 (15.3) | 0 (0.0) | 3 (4.2) | 0.90 | −0.12 |
| Alcohol | 35 (48.6) | 8 (11.1) | 8 (11.1) | 21 (29.2) | 0.40 | 0.34 |
| Benzodiazepines | 61 (84.7) | 5 (6.9) | 2 (2.8) | 4 (5.6) | 0.00 | 0.79 |
| Opioids | 61 (84.7) | 8 (11.1) | 1 (1.4) | 2 (5.6) | 0.33 | 0.26 |
| Variance (%) | 31.57 | 21.57 | ||||
| Patients with prominent use N (%) | 44 (61.1) | 28 (38.9) | ||||
*—Extraction Method: Principal Component Analysis. Rotation Method: Varimax with Kaiser Normalization. THC = Cannabinoids; MDMA = 3,4-metilenediossimetanfetamina; S-CNS = Central Nervous System Stimulants; BDZ = Benzodiazepines.